Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Analyzing eye fluid and tissues to find glaucoma-related markers in people with cataracts.

Official title: Integrated Chemical and Proteomic Analysis of Aqueous Humor and Ocular Tissues in Glaucoma and Cataract Patients

Run by Military Institute od Medicine National Research Institute · NCT07462000 · Data updated 2026-11-12

This study will test whether protein and elemental patterns in eye fluid and tissues taken during cataract surgery differ between people with primary open-angle glaucoma and those without glaucoma.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorMilitary Institute od Medicine National Research Institute
Academic / other
Locations2 sites (Warsaw and 1 other locations)
StatusRecruiting
StartedJanuary 21, 2026
Main results expectedJanuary 21, 2027
Study endsNovember 30, 2027
Registry record updatedMarch 10, 2026
Trial IDNCT07462000 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) scheduled for cataract surgery are eligible, with one arm for patients who have primary open-angle glaucoma planned for combined cataract and glaucoma surgery and a control arm for cataract patients without glaucoma.

Probably not a fit

People with other glaucoma types, prior intraocular surgery, active or prior uveitis, advanced visual loss, pregnancy or breastfeeding, or other significant ocular disease are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect small samples of aqueous humor (~100 µL) and routinely removed ocular tissues during standard cataract surgery, with additional scleral tissue obtained in the glaucoma group. Samples will be analyzed by proteomics (LC-MS/MS) and elemental profiling (ICP-MS, with LA-ICP-MS mapping for selected samples) and interpreted using bioinformatic methods. Participants will receive routine clinical exams including intraocular pressure measurement, optic nerve evaluation, OCT retinal nerve fiber layer analysis, and Humphrey visual fields. The aim is to identify molecular and chemical patterns associated with primary open-angle glaucoma that could serve as diagnostic or prognostic biomarkers.

Why it matters

Potential benefit: If successful, this could reveal biomarkers that help diagnose glaucoma earlier or predict disease progression.

How similar studies have gone: Prior proteomic and elemental analyses of aqueous humor have reported differences associated with glaucoma, but no validated clinical biomarkers have yet been established, so this approach remains exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years.
* Scheduled for cataract surgery (phacoemulsification with intraocular lens implantation).
* Ability to provide written informed consent.
* For glaucoma arm: diagnosis of primary open-angle glaucoma (POAG) with coexisting cataract, and planned combined cataract surgery with glaucoma procedure.
* For control arm: cataract without glaucoma and without other significant ocular pathology.

Exclusion Criteria:

* Age \< 18 years.
* Pregnancy or breastfeeding.
* Advanced visual impairment in the study eye (visual aquity worse than counting fingers).
* Any glaucoma type other than primary open-angle glaucoma (e.g., angle-closure, secondary, neovascular glaucoma).
* History of intraocular surgery in the study eye (including glaucoma surgery), vitreoretinal surgery, corneal transplantation, or refractive surgery.
* Active or previous uveitis.
* Other significant chronic ocular disease in the study eye (other than cataract and POAG in the glaucoma arm).
* Inability to comply with study procedures or follow-up visits.

Where it's running

  • Military Institute of Medicine - National Research Institute
    Warsaw, Poland
    Recruiting
  • University of Warsaw
    Warsaw, Poland
    Recruiting

Study contacts

  • Principal investigator: Marek Rękas, MD, PhD — Military Institute od Medicine National Research Institute
  • Study coordinator: Marek Rękas, MD, PhD
  • Email: mrekas@wim.mil.pl
  • Phone: 0048665 707 626

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.